Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alamanda Polymers is a biotechnology company specializing in the manufacture of high-quality, well-defined polyamino acids (polypeptides) for use in drug delivery and biomedical research. The company provides a wide range of functionalized polymers, including poly-L-lysine, poly-L-glutamic acid, and PEGylated derivatives, which are essential for developing advanced therapeutics like nanoparticle-based delivery systems. Based in Huntsville, Alabama, Alamanda Polymers serves the global pharmaceutical and academic sectors by offering both catalog products and custom synthesis services. Their expertise lies in achieving low polydispersity and high purity in synthetic polypeptides, supporting applications in gene therapy, oncology, and tissue engineering.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alamanda Polymers.